In the News (2.20.15): DePuy agrees to extend current U.S. settlement program for those with a qualifying revision surgery

DePuy Orthopedics (acquired by Johnson & Johnson in 1998) has developed three hip replacement designs since 2000 with high failure rates: the Pinnacle Hip Replacement System, the ASR XL Acetabular System and the ASR Hip Resurfacing System. All three products have problems that arise from their metal-on-metal components. They have voluntarily recalled two (both ASR products) as a result of higher than normal rates of corrective surgery. Prior to the recall, an estimated 93,000 of the ASR and ASR XL products had been sold.

In August 2010, the DePuy ASR metal-on-metal hip implant was recalled after data from the UK joint registry indicated that 12 percent of implants failed within five years of the original implant date. Thirteen percent of patients needed revision surgery five years after receiving an ASR XL Acetabular System.

DePuy Settlement

On Nov. 19, 2013, Johnson & Johnson announced that DePuy Orthopedics Inc. had reached a U.S. settlement agreement to compensate ASR Hip System patients who had surgery to replace their ASR hip. The settlement, valued at approximately $2.5 billion, was based on an estimated 8,000 patients participating in the program.

Johnson & Johnson News Release: DePuy Announces U.S. Settlement Agreement to Compensate ASR Hip System Patients Who Had Surgery to Replace Their ASR Hip

Contact Us For A Free Consultation

For a free and confidential case evaluation, contact us toll free at 888-285-3333 or request a free case evaluation.

For more information regarding DePuy metal hip replacements, please visit: